Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
Lola Sepot-Boucherit, Director Rare Bleeding Disorders at Novo Nordisk, shared a post on LinkedIn:
“Under brilliant Parisian sunshine, the City of Light became a catalyst for scientific exchange, collaboration and innovation at ISTH.
It was a privilege to welcome the global haemostasis community to France and to engage with researchers and healthcare professionals from around the world. Throughout the week, the science on display highlighted how rapidly our field is evolving.
For Novo Nordisk, the congress of the International Society on Thrombosis and Haemostasis (ISTH) also reflected the exciting new chapter we are entering in rare diseases.
As we accelerate research and scientific innovation, the engagement of our Executive Management, including Hong Chow, reinforced our long-term commitment and ambition to help reimagine the future of care for people living with rare bleeding disorders.
It was also a real pleasure to welcome so many Novo Nordisk colleagues to Paris, share a little of the French art de vivre, and spend this memorable week alongside our amazing French team.
See you next year in Vancouver!”

Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide